Physician profile
Carola E Robinson
NPI 1053488247
$4,264.69
in general payments reported to CMS, 2019-2025
36 companies · $711 in 2025
The $711 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $530 · 2021: $543 · 2022: $698 · 2023: $346 · 2024: $305 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.46 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $676.48 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $433.14 | 2019-2025 | |
| Astellas Pharma US INC | $400.62 | 2019-2025 | Veozah |
| Therapeuticsmd, INC. | $388.25 | 2019-2022 | |
| Radius Health, INC. | $241.04 | 2019-2025 | |
| Amgen INC. | $238.27 | 2019-2024 | Evenity, Prolia |
| Exeltis, USA INC. | $214.12 | 2020-2025 | Slynd |
| Millicent US INC | $193.13 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Organon LLC | $187.88 | 2021-2025 | Nexplanon, Nuvaring |
| Duchesnay USA Incorporated | $172.41 | 2019 | |
| Agile Therapeutics, INC. | $133.21 | 2021-2023 | Twirla |
| Medtronic, INC. | $111.32 | 2022-2025 | Truclear |
| Mayne Pharma Commercial LLC | $102.04 | 2024-2025 | |
| Hologic Sales and Service, LLC | $76.60 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Gilead Sciences, INC. | $76.37 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $70.21 | 2021-2023 | Injectafer |
| Allergan, INC. | $55.06 | 2019-2020 | |
| Scynexis, INC. | $49.18 | 2022 | |
| Coopersurgical, INC. | $46.72 | 2019-2020 | |
| Exact Sciences Corporation | $46.65 | 2023-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $41.58 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $35.20 | 2020-2021 | |
| Lupin INC. | $31.78 | 2019 | |
| Vertical Pharmaceuticals, LLC | $26.27 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.10 | 2019 | |
| Biogen, INC. | $23.42 | 2025 | Zurzuvae |
| Novo Nordisk INC | $22.77 | 2025 | Wegovy |
| Seqirus USA INC | $21.65 | 2025 | Flucelvax |
| Lilly USA, LLC | $21.41 | 2025 | Zepbound |
| Medicem INC. | $20.15 | 2020 | |
| Dexcom, INC. | $17.70 | 2025 | Dexcom G6 Transmitter |
| Cepheid | $14.32 | 2025 | |
| Merck Sharp & Dohme LLC | $14.07 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.07 | 2019 | |
| Olympus America INC. | $11.82 | 2019 | |
| Minerva Surgical, INC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carola Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.